Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genetics of occupational asthma development among workers exposed to diisocyanates: A systematic literature review with meta-analysis. | Front Genet | 2022 | 36276967 | PubTator, text mining | PubMed |
| Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. | Nat Commun | 2022 | 36258013 | PubTator, text mining | PubMed |
| Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction. | Int J Nanomedicine | 2022 | 36217495 | PubTator, text mining | PubMed |
| Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma. | J Oncol | 2022 | 36213837 | PubTator, text mining | PubMed |
| Cellular loci involved in the development of brain arteriovenous malformations. | Front Hum Neurosci | 2022 | 36211120 | PubTator, text mining | PubMed |
| Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications. | Hemasphere | 2022 | 36204692 | PubTator, text mining | PubMed |
| Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience. | Neurospine | 2022 | 36203303 | PubTator, text mining | PubMed |
| Aggressive atraumatic myositis ossificans in a toddler. | Radiol Case Rep | 2022 | 36193266 | PubTator, text mining | PubMed |
| Prader-Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings. | Am J Med Genet A | 2022 | 36190479 | PubTator, text mining | PubMed |
| Fibrodysplasia ossificans progressiva: A rare disease with spinal deformity and severe hip dysfunction. | Front Pediatr | 2022 | 36186647 | PubTator, text mining | PubMed |
| Immunotherapy approaches for the treatment of diffuse midline gliomas. | Oncoimmunology | 2022 | 36185807 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva and Pregnancy: A Case Series and Review of the Literature. | Case Rep Obstet Gynecol | 2022 | 36159183 | PubTator, text mining | PubMed |
| A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer. | Front Oncol | 2022 | 36158688 | PubTator, text mining | PubMed |
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models. | J Bone Miner Res | 2022 | 36153796 | PubTator, text mining | PubMed |
| Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. | Vaccines (Basel) | 2022 | 36146527 | PubTator, text mining | PubMed |
| Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies. | Pharmaceutics | 2022 | 36145510 | PubTator, text mining | PubMed |
| Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis. | J Pers Med | 2022 | 36143221 | PubTator, text mining | PubMed |
| Could BMPs Therapy Be Improved if BMPs Were Used in Composition Acting during Bone Formation in Endochondral Ossification? | Int J Mol Sci | 2022 | 36142232 | PubTator, text mining | PubMed |
| Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle. | Diagnostics (Basel) | 2022 | 36140466 | PubTator, text mining | PubMed |
| De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells. | Biomedicines | 2022 | 36140265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=26